Holocene Advisors, LP Vertex Pharmaceuticals Inc Transaction History

Holocene Advisors, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $84,350 - $105,025	359 Added 0.07%	500,130 $141 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $111 Million - $130 Million	499,771 New	499,771 $130 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $488,483 - $546,652	-2,693 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $577,094 - $680,545	-3,078 Reduced 53.34%	2,693 $543,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $413,418 - $481,896	1,997 Added 52.91%	5,771 $1.24 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $781,255 - $1.04 Million	3,774 New	3,774 $892,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $30.2 Million - $35.8 Million	-118,153 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $71.8 Million - $94.3 Million	-318,634 Reduced 72.95%	118,153 $34.3 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $13.2 Million - $16.4 Million	-66,148 Reduced 13.15%	436,787 $104 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $10.7 Million - $14.4 Million	64,252 Added 14.65%	502,935 $110 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $72.9 Million - $82.1 Million	438,683 New	438,683 $74.3 Million
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $196,139 - $228,766	-1,346 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $204,053 - $238,416	1,346 New	1,346 $219,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.